A 72-year-old woman with dense nuclear sclerotic cataract and mild dry eye syndrome (Schirmer test 8 mm/5 min) is scheduled for phacoemulsification. Which topical anti-inflammatory agent is the drug of choice for managing postoperative inflammation while minimizing corneal epithelial toxicity?